Controversial Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits
Links shared publicly online about this topic.
- 1,260total visits
Controversial Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits
View full resource at medicalnewstoday.com
Tags: Heart, Heart Disease, Arrhythmia, Drug, Antiarrhythmic Medication, Multaq
Most Recently Shared on April 6, 2010 at 3:13 pm By:
Controversial Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits http://mnt.to/3zR2 #clinicaltrials
Also Shared By:
Researchers Find New Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits
medicalnewstoday.com — “In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has no” View full resource at medicalnewstoday.com
Most Recently Shared on April 6, 2010 at 4:23 pm By:
MedicalNewsToday: Researchers Find New Arrhythmia Drug Provides Only Modest Efficacy And No: http://bit.ly/adSTC7 Full http://bit.ly/cXYwDQ
New arrhythmia drug provides only modest efficacy and no clear safety benefits, say researchers
sciencedaily.com — “In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers conclude that the controversial drug is only modestly effective and has no clear safety benefits.” View full resource at sciencedaily.com
Most Recently Shared on April 6, 2010 at 1:08 am By:
New arrhythmia drug provides only modest efficacy and no clear safety benefits, say researchers: In a rigorous new... http://bit.ly/d923eV
New arrhythmia drug provides only modest efficacy and no clear safety benefits say researchers
physorg.com — “In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has no clear safety benefits.” View full resource at physorg.com
Most Recently Shared on April 5, 2010 at 10:32 pm By:
Mona Jauhar Health Professional
New arrhythmia drug provides only modest efficacy and no clear safety benefits say researchers: In a rigorous new ... http://bit.ly/azm7g2
Advertisement
medical_tweets
@medical_tweets
Controversial Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits In a rigorous new review of the.. http://dld.bz/dJr
1 year ago...